Navigation Links
Reportlinker Adds Spain Pharmaceutical Market Overview - Price cuts set to negatively impact both branded and generics companies
Date:1/11/2011

NEW YORK, Jan. 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Spain Pharmaceutical Market Overview – Price cuts set to negatively impact both branded and generics companies

http://www.reportlinker.com/p0360216/Spain-Pharmaceutical-Market-Overview – Price-cuts-set-to-negatively-impact-both-branded-and-generics-companies.html

IntroductionThe Spanish prescription pharmaceutical market was valued at $22.1bn in sales in 2009, with an annual growth rate of 6.4% between 2008 and 2009. Key growth drivers include growing use of chronic high-value innovative treatments driven by an aging population, with a high proportion of healthcare expenditure spent on prescription pharmaceuticals.

Features and benefits

* Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property in Spain

* Assesses the size of the Spanish pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies

* Examines the Spanish generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion

* Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis

HighlightsFor newly patented drugs, when deciding on the reimbursement price, the CIPM evaluates a number of factors, including the cost of manufacturing and research and development, cost per day compared with equivalent products in Spain, sales forecast, expected impact on the SNS budget and the product's price in other low-cost European countries.

The Introduction of reference pricing in Spain during 2000, numerous rounds of price cuts, the low price differential between brands and generics, and insufficient physician incentives and the lack of requirement to prescribe by International Non proprietary Name has limited generic penetration as well as the profit potential of generics players.

The Spanish government is trying to restore confidence in the Spanish pharmaceutical market and is working on a strategic plan to develop its sector through increased investment and job creation. Nevertheless, this is still in the early stages and details are yet to be announced.

Your key questions answered* Evaluate the evolving regulatory landscape and the impact of pricing and reimbursement controls on market access in Spain

* Quantify the size and growth of the prescription pharmaceutical market in Spain, analyzing key therapy areas, brands and companies

* Assess drivers and resistors of generic and biosimilars uptake in Spain

To order this report:: Spain Pharmaceutical Market Overview – Price cuts set to negatively impact both branded and generics companies

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Forecast Insight: Antihypertensives - Fixed-dose combinations fail to offset generic erosion
2. Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally
3. Reportlinker Adds The Endoscopy Device Market Outlook to 2015
4. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
5. Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
6. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
7. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
8. Reportlinker Adds France Pharmaceutical Market Overview - Austerity measures will impact pharmaceutical market growth
9. Reportlinker Adds Innovative Drug Discovery in Emerging Markets
10. Reportlinker Adds Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile
11. Reportlinker Adds Cosmetic Surgery Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
(Date:4/26/2017)... Doylestown, Pa. (PRWEB) , ... ... ... Solutions division, which provides an agile ecosystem and domain expertise for sponsors ... end-to-end, configurable randomization and trial supply management (RTSM) software platform. Bioclinica ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... 2017 , ... Lake Park Dental is now accepting new patients with crooked ... FL. With the help of this highly-effective, yet convenient system, patients can straighten their ... and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
Breaking Medicine News(10 mins):